March 19, 2018 2:40 PM ET


Company Overview of Edge Therapeutics, Inc.

Key Executives for Edge Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Brian A. Leuthner 11 RelationshipsCo-Founder, Chief Executive Officer, President and Director52
R. Loch MacDonald M.D., Ph.D.11 RelationshipsCo-Founder, Chief Scientific Officer and Director55
Andrew Saik No RelationshipsChief Financial Officer48
Daniel Brennan 38 RelationshipsChief Operating Officer49
Herbert J. Faleck D.O.No RelationshipsChief Medical Officer64
View More Key Executives

Edge Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Sol J. Barer 89 RelationshipsInspireMD, Inc.70
Brian A. Leuthner 11 RelationshipsEdge Therapeutics, Inc.52
Isaac Blech 103 RelationshipsYuanMing Capital67
R. Loch MacDonald M.D., Ph.D. 11 RelationshipsEdge Therapeutics, Inc.55
Robert S. Langer Jr. 566 RelationshipsInVivo Therapeutics Holdings Corp.68
View All Board Members

Edge Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee CPAJames J. Loughlin21 Relationships3 Executives
Compensation Committee M.D., FACPRobert J. Spiegel47 Relationships1 Executives
Advisory Board Jr.Robert S. Langer566 Relationships1 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$467.5K
Total Value of Options
Compensation as of Fiscal Year
Edge Therapeutics, Inc. CEO Compensation
Industry Average


XBiotech Inc. Appoints Jan-Paul Waldin to its Board of Directors and a Member of Audit Committee and Compensation Committee
March 01, 2018 10:12 PM ET
Cidara Therapeutics, Inc. Appoints Chrysa Mineo to its Board of Directors
March 01, 2018 9:05 PM ET
Biocure Technology Announces Executive Changes
March 01, 2018 6:54 PM ET
Iovance Biotherapeutics Announces Board Changes
March 01, 2018 1:00 PM ET
Alkermes plc Appoints James Robinson as President and Chief Operating Officer, Effective March 5, 2018
March 01, 2018 12:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Edge Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at